Shire hires ex-Merck exec
Executive Summary
Former Merck KGaA global ethical pharmaceuticals president Matthew Emmens named CEO of Shire effective March 19. Emmens succeeds Rolf Stahel, who announced his intention to leave the company in October. Emmens previously spent 19 years at U.S. Merck & Co., and was CEO of Astra Merck joint venture...